Clinical Trials Browser

Esophageal Squamous Cell Carcinoma

Esophageal Neoplasms

Esophageal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Esophageal Squamous Cell Carcinoma

Pancreatic cancer, adult

Pancreatic Neoplasms

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

Urinary Bladder Neoplasms, Neoplasms

Esophageal Neoplasms

Esophageal Squamous Cell Carcinoma

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Pancreatic cancer, adult

Head and Neck Neoplasms

Colorectal Neoplasms

Uterine Cervical Neoplasms

Lung Neoplasms

Pancreatic Cancer Resectable

Pancreatic Neoplasms

Esophageal Neoplasms

Advanced Pancreatic Cancer

Esophageal Neoplasms

Esophageal Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Squamous Cell Carcinoma of Head and Neck

Diffuse Intrinsic Pontine Glioma

Carcinoma, Non-Small-Cell Lung

Uterine Cervical Neoplasms

Nasopharyngeal Carcinoma

Uterine Cervical Neoplasms

Nasopharyngeal Carcinoma

Head and Neck Neoplasms

Nasopharyngeal Carcinoma

Carcinoma, Non-Small-Cell Lung

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms

Penile Neoplasms

Nasopharyngeal Carcinoma

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck

Clinical Trials

Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC

Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer

Neoadjuvant Treatment Modalities in Esophageal Cancer

PIONEER-HN

Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma

Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma

NOTABLE-309

HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients

Nimotuzumab Combined With TGP as First-line Therapy in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial

An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer

Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age

Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma

TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal Carcinoma

Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma

AG Plus Nimotuzumab Sequential Irreversible Electroporation Ablation for Locally Advanced Pancreatic Cancer

A Trial of Nimotuzumab and Pinkiller Efficacy and Pain in Advanced Head and Neck Squamous Cell Carcinoma

Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer

CC11

Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung Carcinoma

Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer

Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer

Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients

Nim-PC-28

A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer

Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment Failure

Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma

Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer

Nimotuzumab Plus AG in Pancreatic Cancer With Liver Metastasis

A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer

NOTABLE-308

Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma

Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer

DIPG

Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer

Nimotuzumab Plus Tislelizumab for Recurrent and Metastatic Cervical Cancer

GNT Induction Treatment in Locally Advanced NPC

Nimotuzumab for EGFR-amplified Advanced Pan Solid Tumors

GCR-05

Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy

Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer

Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma

TRUMP

Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma

TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer

Anti-EGFR Therapy Plus IMRT Concurrent Chemoradiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy

Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer

A Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell Carcinoma

Nimotuzumab Combined With Radiotherapy in High-risk Patients With HNSCC Not Suitable for Cisplatin After Surgery